Related Experiment Video
Updated: Aug 17, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc
Antonio Pineda-Lucena1, Cynthia S W Ho, Daniel Y L Mao
1Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, 610 University Avenue, Toronto, Ont., Canada M5G 2M9.
Abstract:
The N terminus of the c-Myc oncoprotein interacts with Bin1, a ubiquitously expressed nucleocytoplasmic protein with features of a tumor suppressor. The c-Myc/Bin1 interaction is dependent on the highly conserved Myc Box 1 (MB1) sequence of c-Myc. The c-Myc/Bin1 interaction has potential regulatory significance as c-Myc-mediated transformation and apoptosis can be modulated by the expression of Bin1. Multiple splicing of the Bin1 transcript results in ubiquitous, tissue-specific and tumor-specific populations of Bin1 proteins in vivo. We report on the structural features of the interaction between c-Myc and Bin1, and describe two mechanisms by which the binding of different Bin1 isoforms to c-Myc may be regulated in cells. Our findings identify a consensus class II SH3-binding motif in c-Myc and the C-terminal SH3 domain of Bin1 as the primary structure determinants of their interaction. We present biochemical and structural evidence that tumor-specific isoforms of Bin1 are precluded from interaction with c-Myc through an intramolecular polyproline-SH3 domain interaction that inhibits the Bin1 SH3 domain from binding to c-Myc. Furthermore, c-Myc/Bin1 interaction can be inhibited by phosphorylation of c-Myc at Ser62, a functionally important residue found within the c-Myc SH3-binding motif. Our data provide a structure-based model of the c-Myc/Bin1 interaction and suggest a mode of regulation that may be important for c-Myc function as a regulator of gene transcription.
Insights
The c-Myc oncoprotein interacts with the tumor suppressor Bin1 protein. Specific Bin1 isoforms and c-Myc phosphorylation regulate this interaction, impacting cell transformation and gene transcription.
Area of Science:
- Oncology
- Molecular Biology
- Structural Biology
Background:
- c-Myc is an oncoprotein regulating cell growth and apoptosis.
- Bin1 is a nucleocytoplasmic protein with tumor suppressor functions.
- Bin1 splicing generates diverse isoforms with potential roles in cancer.
Purpose of the Study:
- To elucidate the structural basis of the c-Myc/Bin1 interaction.
- To identify mechanisms regulating the binding of different Bin1 isoforms to c-Myc.
- To understand how c-Myc/Bin1 interaction influences oncogenesis and gene transcription.
Main Methods:
- Biochemical assays to study protein interactions.
- Structural biology techniques (e.g., crystallography) to determine binding interfaces.
- Analysis of c-Myc phosphorylation and Bin1 isoform-specific binding.
Main Results:
- Identified a conserved class II SH3-binding motif in c-Myc and the Bin1 SH3 domain as key interaction determinants.
- Demonstrated that tumor-specific Bin1 isoforms are inhibited from binding c-Myc via intramolecular interactions.
- Showed that c-Myc phosphorylation at Ser62 inhibits c-Myc/Bin1 interaction.
Conclusions:
- Provided a structure-based model for c-Myc/Bin1 interaction.
- Uncovered novel regulatory mechanisms involving Bin1 isoforms and c-Myc phosphorylation.
- Highlighted the significance of these interactions in regulating c-Myc's role in gene transcription and cellular processes.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Positive Regulator Molecules
Positive Regulator Molecules

